Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.617EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.383EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.95 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.189EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
C.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.545EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.482EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.564EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.461EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.486EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.603EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.606EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.601EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.186EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.324EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.322EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.416EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.239EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.375EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.432EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.241EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.298EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.433EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.561EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.605EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.596EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
W.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.565EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.361EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.101EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.478EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.543EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.139EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.362EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.265EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used